[{"address1": "4340 East Kentucky Avenue", "address2": "Suite 206", "city": "Glendale", "state": "CO", "zip": "80246", "country": "United States", "phone": "303 495 7583", "website": "https://www.nexienbiopharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard S. Greenberg", "age": 74, "title": "Founder, CEO, Executive VP & Chairman", "yearBorn": 1949, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Evan L. Wasoff CPA", "age": 75, "title": "Chief Financial Officer", "yearBorn": 1948, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert I. Goldfarb J.D., Esq.", "age": 67, "title": "Chief Operating Officer", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 55000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.0265, "open": 0.02, "dayLow": 0.011, "dayHigh": 0.0223, "regularMarketPreviousClose": 0.0265, "regularMarketOpen": 0.02, "regularMarketDayLow": 0.011, "regularMarketDayHigh": 0.0223, "beta": 1.562, "volume": 16279, "regularMarketVolume": 16279, "averageVolume": 11885, "averageVolume10days": 16990, "averageDailyVolume10Day": 16990, "marketCap": 717994, "fiftyTwoWeekLow": 0.011, "fiftyTwoWeekHigh": 0.1, "fiftyDayAverage": 0.02386, "twoHundredDayAverage": 0.031305, "currency": "USD", "enterpriseValue": 976823, "floatShares": 23766912, "sharesOutstanding": 65272200, "heldPercentInsiders": 0.55928004, "impliedSharesOutstanding": 65272200, "bookValue": -0.004, "lastFiscalYearEnd": 1688083200, "nextFiscalYearEnd": 1719705600, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -341946, "trailingEps": -0.01, "52WeekChange": -0.25, "SandP52WeekChange": 0.22382951, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "NXEN", "underlyingSymbol": "NXEN", "shortName": "NEXIEN BIOPHARMA INC", "longName": "Nexien BioPharma, Inc.", "firstTradeDateEpochUtc": 1511965800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "c0874875-57e0-3560-a14b-1981be99240b", "messageBoardId": "finmb_540773634", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.011, "recommendationKey": "none", "totalCash": 18064, "totalDebt": 276893, "quickRatio": 0.058, "currentRatio": 0.07, "returnOnAssets": -2.6600602, "freeCashflow": 20646, "operatingCashflow": -83084, "financialCurrency": "USD", "trailingPegRatio": null}]